Mononuclear Co(III), Ni(II) and Cu(II) complexes of tridentate di‐tert‐butylphenylhydrazone: Synthesis,characterization, X‐ray crystal structures,Hirshfeld surface analysis,molecular docking and in vivo anti‐inflammatory activity

A new hydrazone (LH₂) derived from the condensation of 2‐(4‐fluorobenzamido)benzohydrazide with 3,5‐di‐tert‐butyl‐2‐hydroxybenzaldehyde was used to synthesize Co(III), Ni(II) and Cu(II) complexes. These were characterized using various physicochemical, thermal, spectroscopic and single‐crystal X‐ray diffraction techniques. All the complexes crystallize in a monoclinic crystal system with P2₁/n space group and Z = 4. Structural studies of [Co(L)(LH)]?H₂O indicate the presence of both amido and imidol tautomeric forms of the ligand, resulting in a distorted octahedral geometry around the Co(III) ion. On the other hand, in the [Ni(L)(DMF)] and [Cu(L)(H₂O)] complexes, the ligand coordinates to the metal through imidol form resulting in distorted square planar geometry, in which the fourth position is occupied by the oxygen of coordinated DMF in [Ni(L)(DMF)] and by a water molecule in [Cu(L)(H₂O)]. Hirshfeld surface calculations were performed to explore hydrogen bonding and C―H???π interactions. Molecular docking studies were carried out to study the interaction between the synthesized compounds and proteins (cyclooxygenase‐2 and 5‐lipoxygenase). The complexes along with the parent ligand were screened for their in vivo anti‐inflammatory activity, using the carrageenan‐induced rat paw oedema method. The complexes show significant anti‐inflammatory potencies.     

The antioxidant methyl 3‐(3,5‐di‐tert‐butyl‐4‐hydroxyphenyl)propionate

The title compound, C₁₈H₂₈O₃, was prepared by the reaction of 2,6‐di‐tert‐butylphenol with methyl acrylate under basic conditions using dimethyl sulfoxide as the promoter. The structure of this antioxidant indicates significant strain between the ortho tert‐butyl substituents and the phenolic OH group. In spite of the steric crowding of the OH group, it participates in intermolecular hydrogen bonding with the ester carbonyl O atom.     

Novel 2-formylpyridine 4-allyl-S-methylisothiosemicarbazone and Zn(II), Cu(II), Ni(II) and Co(III) complexes: Synthesis,characterization, crystal structure,antioxidant, antimicrobial and antiproliferative activity

New zinc (II), copper (II), nickel (II) and cobalt (III) complexes, [Zn (HL)₂]I₂ (1) , [Cu (HL)Cl₂] (2) , [Cu (HL)Br₂] (3) , [Cu (HL)(H₂O)₂](ClO₄)₂ (4) , [Ni (HL)₂]I₂·H₂O (5) , [Co(L)₂]Cl (6) , [Co(L)₂]NO₃ (7) , [Co(L)₂]I·[Co(L)₂](I₃) (8) were obtained with 2-formylpyridine 4-allyl-S-methylisothiosemicarbazone ( HL ). The isothiosemicarbazone ligand was characterized by NMR (¹H and ¹³C), IR spectroscopy and X-ray diffraction. All the complexes were characterized by elemental analysis, IR, UV–Vis, ESI-MS spectroscopy, molar conductivity, magnetic susceptibility measurements. X-ray diffraction analysis on the monocrystal and powder elucidated the structure of the complexes 1 , 5 , 7 and 8 . The ligand and the complexes were tested for their antioxidant and antimicrobial activity against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Candida albicans. Also, the antiproliferative properties of these compounds on human leukemia HL-60, human cervical epithelial HeLa, human epithelial pancreatic adenocarcinoma BxPC-3, human muscle rhabdomyosarcoma spindle, large multinucleated RD cells and normal MDCK cells have been investigated. The nickel complex 5 and cobalt complexes 6 , 7 showed promising antiproliferative activity and low toxicity.     

Anti‐proliferative activity of newly synthesized Cd(II), Cu(II), Zn(II),Ni(II), Co(II), VO(II), and Mn(II) complexes of 2‐((4,9‐dimethoxy‐5‐oxo‐5H‐furo[3,2‐g]chromen‐6‐yl)methylene) hydrazinecarbothioamide on three human cancer cells

Thiosemicarbazone ligand, 2‐((4,9‐dimethoxy‐5‐oxo‐5H‐furo[3,2‐g]chromen‐6‐yl)methylene) hydrazinecarbothioamide and its Cd(II), Cu(II), Zn(II), Ni(II), Co(II), VO(II), and Mn(II) complexes have been prepared and characterized by various spectroscopic and analytical techniques. Complexes molar conductance measurements displayed that all complexes (2–8) are non‐electrolyte. With general composition [M(H₃L)(CH₃COO)₂H₂O].nH₂O, where M = Cd(II), Cu(II), Zn(II), Ni(II), Co(II) and Mn(II) while complex (8) has [VO(H₃L)(SO₄)H₂O].2H₂O formula. Based on analytical and spectral measurements, the octahedral or distorted octahedral geometries suggested for complexes. Ligand and complexes anti‐proliferative activities were assessed against three various human tumor cell lines including breast cancer (MCF‐7), liver cancer (HepG2) and lung cancer (A549) using SRB fluorometric assay and cis‐platin as positive control. The anti‐proliferative activity result indicated that the ligand and its complexes have considerable anti‐proliferative activity analogous to that of ordinarily utilized anti‐cancer drug (cis‐platin). They do their anti‐cancer activities by modifying free radical's generation via raising the superoxide dismutase activity and depletion of intracellular reduced glutathione level, catalase, glutathione peroxidase activities, escorted by highly generation of hydrogen peroxide, nitric oxide and other free radicals leading to tumor cells death, as monitoring by decreasing the protein and nucleic acids synthesis.     

Preparation,antitumor activity in mice,pharmacokinetics and tissue distribution in rats of di‐n‐butyl‐di‐(4‐chlorobenzohydroxamato)tin(IV) liposome

Di‐n‐butyl‐di‐(4‐chlorobenzohydroxamato)tin(IV) (DBDCT) is an antitumor compound with high activity and relatively low bioavailability. In order to improve the pharmacokinetic characteristics and raise its therapeutic index, a liposome of DBDCT (DBDCT‐L) was prepared for the first time. A study of the pharmacokinetics and tissue distribution after intravenous administration of DBDCT‐L compared with free DBDCT to rats was investigated. DBDCT‐L showed a slower clearance, increased half‐time and a larger AUC value than those of free DBDCT, which demonstrated that DBDCT‐L could significantly alter the tissue distribution pattern of DBDCT in rats. The highest concentration distribution for DBDCT‐L was detected in liver, which may be associated with the enhanced antitumor activity in vivo against hepatocellular carcinoma H₂₂ and possible target release of the compound. Acute toxicity assay showed that the LD₅₀ value of DBDCT‐L was higher than that of free DBDCT. Further in vivo antitumor test showed that DBDCT‐L displayed higher antitumor activity against the hepatocellular carcinoma H₂₂ than free DBDCT, indicating that the liposome could prolong the action time of DBDCT in the system circulation, change its distribution in rats, reduce acute toxicity and finally increase antitumor activity. Copyright © 2014 John Wiley & Sons, Ltd.     

Co(II), Ni(II), Cu(II) and Zn(II) complexes of isatinyl‐2‐aminobenzoylhydrazone: synthesis,characterization and anticancer activity

This article describes the synthesis, structural aspects and biological studies of Co(II), Ni(II), Cu(II) and Zn(II) complexes of a new hydrazone derived from the condensation of isatin and 2‐aminobenzoylhydrazide. The ligand is well characterized using ¹H NMR, ¹³C NMR, 2D HETCOR, mass and IR spectral studies. The chelating tendency of the ligand towards transition metal ions is established using analytical and spectral studies, which reveal the monobasic tridentate nature of the ligand. Octahedral geometry for Co(II), Cu(II) and Zn(II) and tetrahedral geometry for Ni(II) are tentatively proposed. All the synthesized compounds were screened for in vitro anticancer activity against Ehrlich ascites carcinoma and human cancer cell lines (adenocarcinoma HT29, kidney cancer cell line K293 and breast cancer cell line MDA231) using tryphan blue exclusion method and MTT assay. Copyright © 2014 John Wiley & Sons, Ltd.     

Synthesis,characterization, anti‐inflammatory and analgesic activity of transition metal complexes of 3‐[1‐(2‐hydroxyphenyl) ethylideamino]‐2‐phenyl‐3,4‐dihydroquinazolin‐4(3H)‐one

A new quinazolinone derivative, 3‐[1‐(2‐hydroxyphenyl)ethylideamino]‐2‐phenyl‐3,4‐dihydroquinazolin‐4(3H)‐one ( LH ) was synthesized by the condensation of 2‐hydroxyacetophenone‐2‐aminobenzoylhydrazone and benzaldehyde. The cyclization to form 1,2‐dihydroquinazolinone was confirmed by IR, 1D and 2D HETCOR studies. Coordination compounds of Co(II), Ni(II), Cu(II) and Zn(II) of LH were synthesized and characterized using various physico‐chemical studies like stoichiometric, conductivity, magnetic moment measurements and spectral techniques such as IR, NMR, UV‐vis and EPR spectroscopy. The elemental analysis and thermal studies suggested a general stoichiometry [M(HEPDQ)Cl] for all the complexes. A four‐coordinate geometry was assigned to all the complexes. The complexes along with the parent ligand were screened for their anti‐inflammatory activity, using carrageenan‐induced rat paw edema, and for their analgesic activity by Eddy's hot plate method. The activity of the ligand was enhanced on complexation with metal ions. This enhanced activity was attributed to the increased lipophilic nature of the complexes. Notable anti‐inflammatory activity was observed for Ni(II), Cu(II) and Zn(II) complexes. The analgesic activity of the ligand was greater than the standard at 60 min. and at a 10 mg kg⁻¹ dose, whereas the activity of Ni(II) and Cu(II) complexes at 10 mg kg⁻¹ dose was comparable with the standard used. Copyright © 2011 John Wiley & Sons, Ltd.     

Synthesis and biological activity of novel N‐benzoyl‐N‐tert‐butyl‐N′‐(β‐triphenylgermyl)propionylhydrazines

A series of new N‐benzoyl‐N‐tert‐butyl‐N′‐(β‐triphenylgermyl)propionylhydrazines were synthesized by the condensation reaction of β‐triphenylgermyl propanoic acid with N‐benzoyl‐N‐tert‐butylhydrazines in good yields by using N,N′‐dicyclohexylcorbodiimide as dehydrating agent. These title compounds were evaluated for molting hormone mimicking activity. The results of bioassay showed that the compounds exhibit moderate larvicidal activity, and toxicity assays indicated that the title compounds can induce a premature, abnormal and lethal larval molt. We found that the title compounds possess potential anticancer activities in vitro. Copyright © 2002 John Wiley & Sons, Ltd.     

Synthesis,characterization, crystal structure and toxicity evaluation of Co (II), Cu (II), Mn (II), Ni (II), Pd (II) and Pt (II) complexes with Schiff base derived from 2-chloro-5-(trifluoromethyl)aniline

A bidentate NO donor Schiff base, 2-(((2-chloro-5- (trifluoromethyl)phenyl)imino)methyl) phenol ( HL ¹ ) and its complexes [Co(L¹)₂(H₂O)₂] ( 1 ), [Cu(L¹)₂] ( 2 ), [Mn(L¹)₂(H₂O)₂] ( 3 ), [Ni(L¹)₂(H₂O)₂] ( 4 ), [Pd₂(L¹)₂(OAc)₂·1.16H₂O] ( 5 ), [Pt(L¹)₂] ( 6 ) were synthesized and characterized by different physico-chemical techniques including elemental and thermal analysis, magnetic susceptibility measurements, molar electric conductivity, IR, ¹H-NMR, ¹³C-NMR, UV–Vis, mass spectroscopies and X-ray powder diffraction (XRD). The molecular structures of ligand HL ¹ and two complexes ( 2 and 5 ) were confirmed by X-ray crystallography analysis on the monocrystal. In this complexes, the metal ions are in distorted square-planar environments. The copper (II) complex is mononuclear and crystallized in a monoclinic space group P21/c, whereas palladium (II) complex is dinuclear and crystallized in the trigonal crystal system R-3. The toxicity of the ligand and complexes was evaluated on both plant and animal cells, using the plant species Triticum aestivum L. and the crustacean Artemia franciscana Kellogg. At concentrations up to 100 μM the compounds presented very little toxicity on Artemia franciscana Kellogg. Moreover, the palladium (II) complex was devoid of any toxicity on the plant cells.     

Synthesis and biological activity of novel N‐tert‐butyl‐N,N′‐substitutedbenzoylhydrazines containing 2‐methyl‐3‐(triphenylgermanyl)propoxycarbonyl

In a search for new insect growth regulators with unusual biological properties and different activity spectrum, we thought that the preservation of the bioactive unit and the introduction of 2‐methyl‐3‐(triphenylgermanyl)propoxycarbonyl in N‐tert‐butyl‐N,N′‐dibenzoylhydrazine would enhance their larvicidal activities to a significant degree. Therefore, we designed and synthesized N′‐tert‐butyl‐N′‐[2‐methyl‐3‐(triphenylgermanyl)propoxycarbonyl]‐N‐benzoylhydrazine and analogs by two procedures. These novel compounds were characterized by elemental analyses, IR, and ¹H NMR. At the same time, N‐tert‐butyl‐N‐substitutedbenzoylhydrazines were prepared by a new method, and some reactions involved were studied. The preliminary results indicate that some compounds have inhibitory effects against plant pathogenetic bacteria such as early blight of tomato. Copyright © 2002 John Wiley & Sons, Ltd.     

Biological evaluation of organometallic palladium(II) complexes containing 4‐hydroxybenzoic acid (3‐ethoxy‐2‐hydroxybenzylidene)hydrazide: Synthesis,structure, DNA/protein binding,antioxidant activity and cytotoxicity

New palladium(II) complexes, [Pd(PPh₃)L] ( 2 ) and [Pd(AsPh₃)L] ( 3 ), were synthesized using 4‐hydroxybenzoic acid (3‐ethoxy‐2‐hydroxybenzylidene)hydrazide ( 1 ) ligand (H₂L), and characterized using various physicochemical techniques. The molecular structures of 2 and 3 were determined using single‐crystal X‐ray diffraction, which reveals a square planar geometry around the palladium(II) metal ion. In vitro DNA binding studies were conducted using UV–visible absorption spectroscopy, emission spectroscopy, cyclic voltammetry and viscosity measurements, which suggest that the metal complexes act as efficient DNA binders. The interaction of ligand H₂L and complexes 2 and 3 with bovine serum albumin (BSA) was investigated using UV–visible and fluorescence spectroscopies. Absorption and emission spectral studies indicate that complexes 2 and 3 interact with BSA protein more strongly than the parent ligand. The free radical scavenging potential of all the synthesised compounds ( 1 – 3 ) was also investigated under in vitro conditions. In addition, the in vitro cytotoxicity of the complexes to tumour cells lines (HeLa and MCF‐7) was examined using the MTT assay method.     

Salisaldehyde-2-aminobenzimidazole schiff base complexes of Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II)

New metal complexes of Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) with salicylidine-2-aminobenzimidazole (SABI) are synthesized and their physicochemical properties are investigated using elemental and thermal analyses, IR, conductometric, solid reflectance and magnetic susceptibility measurements. The base reacts with these metal ions to give 1:1 (Metal:SABI) complexes; in cases of Fe(III), Co(II), Cu(II), Zn(II) and Cd(II) ions; and 1:2 (Metal:SABI) complexes; in case of Ni(II) ion. The conductance data reveal that Fe(III) complex is 2:1 electrolyte, Co(II) is 1:2 electrolyte, Cu(II), Zn(II) and Cd(II) complexes are 1:1 electrolytes while Ni(II) is non-electrolyte. IR spectra showed that the ligand is coordinated to the metal ions in a terdentate mannar with O, N, N donor sites of the phenloic -OH, azomethine -N and benzimidazole -N3. Magnetic and solid reflectance spectra are used to infer the coordinating capacity of the ligand and the geometrical structure of these complexes. The thermal decomposition of the complexes is studied and indicates that not only the coordinated and/or crystallization water is lost but also that the decomposition of the ligand from the complexes is necessary to interpret the successive mass loss. Different thermodynamic activation parameters are also reported, using Coats-Redfern method. This revised version was published online in July 2006 with corrections to the Cover Date.     

Synthesis,spectroscopic characterization,biological screening and in vitro cytotoxic studies of 4‐methyl‐3‐thiosemicarbazone derived Schiff bases and their Co (II), Ni (II), Cu (II) and Zn (II) complexes

A series of twenty compounds inclusive of bidentate Schiff bases derived from condensation of 4‐methyl‐3‐thiosemicarbazide with substituted derivatives of napthaldehyde/benzaldehyde/salicylaldehyde and their mononuclear Co (II), Ni (II), Cu (II) and Zn (II) complexes in molar ratio (1:1) were synthesized and characterized. The coordination behavior, modes of bonding and overall geometry of the compounds was known from the elemental analysis, spectral techniques (IR, UV–Vis, ¹H NMR, ¹³C NMR, ESR and ESI‐mass), magnetic moment measurements, molar conductance, thermal and powder XRD studies. The studies revealed octahedral geometry for all the complexes where ligands coordinated in a neutral bidentate manner (NS) via nitrogen atom of azomethine group and sulphur atom of thione group with the metal centre. In vitro biological effects of the compounds were tested against four bacterial species and two fungal strains. The results indicated that the metal complexes showed a marked enhancement in biocidal activity in comparable with the parent Schiff bases. In vitro anticancer activity against the malignant tumor cell lines; human alveolar adenocarcinoma epithelial cell line (A549), human breast adenocarcinoma cell line (MCF7), human prostate cancer cell line (DU145) and human normal lung cell line (MRC‐5) using MTT assay, exposed compound 16 as a leading member with lowest IC₅₀ value of 10.6 ± 0.14 μM against (A549) cell line.     

Attempt to Synthesize Hindered 2,4,6‐Tri‐Aryloxy‐s‐Triazines: Bis(2,4‐di‐tert‐Butylphenyl) Carbonate – Crystal Structure

Some less hindered 2,4,6‐tri‐aryloxy‐s‐triazines were synthesized through the reaction of the corresponding phenols as a starting materials with cyanogen bromide (BrCN) to obtain the corresponding arylcyanates and then trimerized. Unexpectedly, 2,4‐di‐tert‐butyl‐1‐cyanatobenzene derived from 2,4‐di‐tert‐butylphenol did not trimerize but, indeed, yielded bis(2,4‐di‐tert‐butylphenyl) carbonate. The structures of 2,4,6‐tri‐aryloxy‐s‐triazines and bis(2,4‐di‐tert‐butylphenyl) carbonate were characterized by means of IR, ¹H, and ¹³C NMR spectroscopies. Also the structure of the latter compound was studied by X‐ray crystallography.     

Synthesis, thermal and other studies of 2,4'-bipyridine-dichloroacetato complexes of Mn(II), Co(II), Ni(II) and Cu(II)

Four new mixed ligand complexes were prepared by the reaction of title metal dichloroacetates and 2,4'-bipyridine. The general formulae of synthesized compounds are M(2,4'-bpy)₂(CCl₂HCOO)₂·nH₂O (where M(II)=Mn, Co, Ni, Cu; 2,4'-bpy=2,4'-bipyridine, n=2 or 4). The complexes have been isolated from aqueous media and characterized by chemical analysis, molar conductance (in MeOH, DMSO and DMF), magnetic, IR and VIS spectral studies. The nature of metal(II)-ligand coordination is discussed. The thermal behaviour of obtained complexes was studied by thermal analysis and TG-MS techniques in air. IR, X-ray powder diffraction and thermoanalytical data were used for the determination of solid intermediate products of the thermal decomposition. The principal volatile products of thermal decomposition of complexes were proved by mass spectroscopy: H₂O⁺, CO⁺ ₂, HCl⁺ ₂, Cl⁺ ₂, NO⁺ and other. This revised version was published online in July 2006 with corrections to the Cover Date.     

Preparation,Characterization, Biological Activity and 3D Molecular Modeling of Mn(II), Co(II), Ni(II), Cu(II), Pd(II) and Ru(III) Complexes of Some Sulfadrug Schiff Bases

Mn(II), Co(II), Ni(II), Cu(II), Pd(II) and Ru(III) complexes of Schiff bases derived from the condensation of sulfaguanidine with 2,4‐dihydroxy benzaldehyde ( HL1 ), 2‐hydroxy‐1‐naphthaldehyde ( HL2 ) and salicylaldehyde ( HL3 ) have been synthesized. The structures of the prepared metal complexes were proposed based on elemental analysis, molar conductance, thermal analysis (TGA, DSC and DTG), magnetic susceptibility measurements and spectroscopic techniques (IR, UV‐Vis, and ESR). In all complexes, the ligand bonds to the metal ion through the azomethine nitrogen and α‐hydroxy oxygen atoms. The structures of Pd(II) complex 8 and Ru(III) complex 9 were found to be polynuclear. Two kinds of stereochemical geometries; distorted tetrahedral and distorted square pyramidal, have been realized for the Cu(II) complexes based on the results of UV‐Vis, magnetic susceptibility and ESR spectra whereas octahedral geometry was predicted for Co(II), Mn(II) and Ru(III) complexes. Ni(II) complexes were predicted to be square planar and tetrahedral and Pd(II) complexes were found to be square planar. The antimicrobial activity of the ligands and their metal complexes was also investigated against the gram‐positive bacteria Staphylococcus aures and Bacillus subtilis and gram‐negative bacteria, Escherichia coli and Pesudomonas aeruginosa, by using the agar dilution method. Chloramphenicol was used as standard compound. The obtained data revealed that the metal complexes are more or less, active than the parent ligand and standard. The X‐ray crystal structure of HL3 has been also reported.     

Synthesis,Structural, Biological Evaluation,Molecular Docking and DFT Studies of Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and Hg(II) Complexes bearing Heterocyclic Thiosemicarbazone ligand

A new ligand, 2‐aminonicotinaldehyde N‐methyl thiosemicarbazone (ANMTSC) and its metal complexes [Co(II) ( 1 ); Ni(II) ( 2 ); Cu(II) ( 3 ); Zn(II) ( 4 ); Cd(II) ( 5 ) or Hg(II) ( 6 )] were synthesized. The compounds were characterized by analytical methods and various spectroscopic (infrared, magnetic, thermal, ¹H, ¹³C NMR, electronic and ESR) tools. The structure of ANMTSC ligand was confirmed by single crystal X‐ray diffraction study. The spectral data of metal complexes indicate that the ligand acts as mononegative, bidentate coordination through imine nitrogen (N) and thiocarbonyl sulphur (S^?) atoms. The proposed geometries for complexes were octahedral ( 1 – 2 ), distorted octahedral ( 3 ) and tetrahedral ( 4 – 6 ). Computational details of theoretical calculations (DFT) of complexes have been discussed. The compounds were subjected to antimicrobial, antioxidant, antidiabetic, anticancer, ROS, studies and EGFR targeting molecular docking analysis. Complex 5 has shown excellent antibacterial activity and the complexes 2 and 5 have shown good antifungal activity. The complexes 1 and 4 displayed good antioxidant property with IC₅₀ values of 11.17 ± 1.92 μM and 10.79 ± 1.85 μM, respectively compared to standard. In addition, in vitro anticancer activity of the compounds was investigated against HeLa, MCF‐7, A549, IMR‐32 and HEK 293 cell lines. Among all the compounds, complex 4 was more effective against HeLa (IC₅₀ = 10.28 ± 0.69 μM), MCF‐7 (IC₅₀ = 9.80 ± 0.83 μM), A549 (IC₅₀ = 11.08 ± 0.57 μM) and IMR‐32 (10.41 ± 0.60 μM) exhibited superior anticancer activity [IC₅₀ = 9.80 ± 0.83 ( 4 ) and 9.91 ± 0.37 μM ( 1 )] against MCF‐7 compared with other complexes.     

Heteronuclear complexes of oxorhenium(V) with Fe(III), Co(II), Ni(II), Cu(II), Cd(II) and UO2(VI) and their biological activities

Heteronuclear complexes containing oxorhenium(V), with Fe(III), Co(II), Ni(II), Cu(II), Cd(II) and UO₂(VI) ions were prepared by the reaction of the complex ligands [ReO(HL¹)(PPh₃)(OH₂)Cl]Cl (a) and/or [ReO(H₂L²)(PPh₃)(OH₂)Cl]Cl (b), where H₂L¹?=?1-(2-hydroxyphenyl)butane-1,3-dione-3-(5,6-diphenyl-1,2,4-triazine-3-ylhydrazone) and H₃L²?=?1-(2-hydroxyphenyl)butane-1,3-dione-3-(1H-benzimidazol-2-ylhydrazone), with transition and actinide salts. Heterodinuclear complexes of ReO(V) with Fe(III), Co(II), Ni(II), Cu(II) and Cd(II) were obtained using a 1?:?1 mole ratio of the complex ligand and the metal salt. Heterotrinuclear complexes were obtained containing ReO(V) with UO₂(VI) and Cu(II) using 2?:?1 mole ratios of the complex ligand and the metal salts. The complex ligands a and b coordinate with the heterometal ion via a nitrogen of the heterocyclic ring and the nitrogen atom of the C=N⁷ group. All transition metal cations in the heteronuclear complexes have octahedral configurations, while UO₂(VI)?complexes have distorted dodecahedral geometry. The structures of the complexes were elucidated by IR, ESR, electronic and ¹H NMR spectra, magnetic moments, conductance and TG-DSC measurements. The antifungal activities of the complex ligands and their heteronuclear complexes towards Alternaria alternata and Aspergillus niger showed comparable behavior with some well-known antibiotics.     

Synthesis,crystal structures and luminescence properties of seven mononuclear zinc(II), cadmium(II), cobalt(II) and nickel(II) complexes with 5‐(4‐methylphenyl)‐3‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazole

Due to their versatile coordination modes and metal‐binding conformations, triazolyl ligands can provide a wide range of possibilities for the construction of supramolecular structures. Seven mononuclear transition metal complexes with different structural forms, namely aquabis[3‐(4‐methylphenyl)‐5‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazolato‐κ²N ¹,N ⁵]zinc(II), [Zn(C₁₄H₁₁N₄)₂(H₂O)], (I), bis[5‐(4‐methylphenyl)‐3‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazole‐κ²N ³,N ⁴]bis(nitrato‐κO )zinc(II), [Zn(NO₃)₂(C₁₄H₁₂N₄)₂], (II), bis(methanol‐κO )bis[3‐(4‐methylphenyl)‐5‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazolato‐κ²N ¹,N ⁵]zinc(II), [Zn(C₁₄H₁₁N₄)₂(CH₄O)₂], (III), diiodidobis[5‐(4‐methylphenyl)‐3‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazole‐κ²N ³,N ⁴]cadmium(II), [CdI₂(C₁₄H₁₂N₄)₂], (IV), bis[5‐(4‐methylphenyl)‐3‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazole‐κ²N ³,N ⁴]bis(nitrato‐κO )cadmium(II), [Cd(NO₃)₂(C₁₄H₁₂N₄)₂], (V), aquabis[3‐(4‐methylphenyl)‐5‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazolato‐κ²N ¹,N ⁵]cobalt(II), [Co(C₁₄H₁₁N₄)₂(H₂O)], (VI), and diaquabis[3‐(4‐methylphenyl)‐5‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazolato‐κ²N ¹,N ⁵]nickel(II), [Ni(C₁₄H₁₁N₄)₂(H₂O)₂], (VII), have been prepared by the reaction of transition metal salts (Zn^II, Cd^II, Co^II and Ni^II) with 3‐(4‐methylphenyl)‐5‐(pyridin‐2‐yl)‐1H‐1,2,4‐triazole (pymphtzH) under either ambient or hydrothermal conditions. These compounds have been characterized by elemental analysis, IR spectroscopy and single‐crystal X‐ray diffraction. All the complexes form three‐dimensional supramolecular structures through hydrogen bonds or through π–π stacking interactions between the centroids of the pyridyl or arene rings. The pymphtzH and pymphtz⁻ entities act as bidentate coordinating ligands in each structure. Moreover, all the pyridyl N atoms are coordinated to metal atoms (Zn, Cd, Co or Ni). The N atom in the 4‐position of the triazole group is coordinated to the Zn and Cd atoms in the crystal structures of (II), (IV) and (V), while the N atom in the 1‐position of the triazolate group is coordinated to the Zn, Co and Ni atoms in (I), (III), (VI) and (VII).     

4‐Hydroxy‐3‐carboxycoumarin as an efficient building block for new ruthenium(II) complexes: synthesis,characterization, antibacterial,antioxidant and anti‐inflammatory activities

A new 4‐hydroxy‐3‐carboxycoumarin ligand and its ruthenium(II) complexes ( 1 – 5 ) have been synthesized, characterized and screened for their in vitro antibacterial activity against a range of Gram‐positive and Gram‐negative bacteria. In addition, compounds 1 – 5 were investigated for antioxidant activities using superoxide radical, 2,2‐diphenyl‐1‐picrylhydrazyl radical and hydroxyl radical scavenging assays, in which most of them displayed significant antioxidant activities. Furthermore, compounds 1 – 5 were evaluated for anti‐inflammatory activity using indirect haemolytic and lipoxygenase inhibition assays and revealed good activity. The new complexes were characterized using spectroscopic methods in addition to elemental analysis.